A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04150913 |
|
Recruitment Status :
Active, not recruiting
First Posted : November 5, 2019
Last Update Posted : April 23, 2024
|
Sponsor:
Marcela V. Maus, M.D.,Ph.D.
Collaborator:
Kite, A Gilead Company
Information provided by (Responsible Party):
Marcela V. Maus, M.D.,Ph.D., Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | October 30, 2024 |
| Estimated Study Completion Date : | October 31, 2025 |